Peptic ulcer is a common gastrointestinal disease and produces mucosa erosion. The current study assessed the ability of burdock essence to repair gastrointestinal mucosa in clinical trials. In the experimental group, two tablets of burdock essence (500 mg/tablet) were administered three times a day after meals and a placebo was administered in controls. Four weeks after drug administration, the subjects in the study underwent an assessment for the efficacy of burdock essence as health supplements before and after administration of the drug. The presence of gastric mucosal lesions was determined in all of the peptic ulcer patients using electronic endoscopy before and after taking burdock essence. A rapid urease test on tissue samples from ulcers was conducted to verify Helicobacter pylori infection. Endoscopy confirmed gastric or duodenal ulcers in 30 patients. In clinical trials of 27 patients, 20 patients took burdock essence; 17 (85%) recovered completely and three (15%) did not. Of the seven patients who took placebos, five (71%) did not completely recover and two (29%) recovered. In the experimental group, the ulcer wounds of the three patients who had taken burdock essence did not completely heal, but wounds were reduced in size by 30%, 75%, and 33%. Moreover, 10 out of 11 patients who originally were positive for H. pylori infections no longer had the pathogen by the end of the trial. These results indicate that burdock essence has an inhibitory effect on H. pylori. This study confirms that two tablets (500 mg/tablet) of burdock essence taken orally three times a day after meals can help abolish H. pylori infection and promote the therapeutic effect of conventional medication on gastric mucosal repair in gastrointestinal ulcer patients.
Introduction
Peptic ulcers are a very common digestive disease. A total of 5−10% of the population has peptic ulcers. 1 In Taiwan, approximately 1 million people have sought medical treatment and have taken medication for peptic ulcers. Moreover, peptic ulcer-related gastric cancer ranked fifth among the top 10 causes of cancer deaths in 2005, which represents a potential crisis and a huge medical burden. Following the discovery of Helicobacter pylori by Marshall and Warren in 1982, 2 peptic ulcer treatment underwent a major change. It was finally established that H. pylori infection is associated with numerous diseases and is the main cause of peptic ulcers. Approximately 95% of duodenal ulcers and 70% of gastric ulcers are associated with H. pylori leading to changes in treatment, from traditional surgery to drug-based internal medicine. 3 Studies have shown that in peptic ulcers with H. pylori infection, failure to eradicate H. pylori results in a recurrence rate of 60−95% after stopping medication. 4 In contrast, if H. pylori is eradicated, the recurrence rate is reduced to 20%. Clinically, it is, therefore, generally believed that as soon as an H. pylori infection is identified, eradication therapy should be administered.
To treat an H. pylori infection, routine clinical medical intervention is carried out, and specific acid drugs are combined with antibiotics (including amoxicillin, tetracycline, and clarithromycin). 5 However, side effects such as allergies, nausea, bloating and general fatigue may be experienced. 6 In addition, long-term antibiotic use can also result in the accumulation of antibiotics inside the body. Complementary approaches may alleviate the discomfort felt by a patient, and therefore, a physician or patient may consider these as options.
Burdock (Arctium lappa L.) is an herbaceous plant of the Asteraceae family. Burdock roots are similar in shape to those of ginseng, and the Japanese, the world's longest-living people, incorporate burdock into the diet because of its high nutritional value. It is rich in its nutritional composition including insulin, polyphenols, chlorogenic acid, protein, carbohydrate, vitamin groups, amino acids, minerals, and unsaturated acids. Its carotene content is 150 times higher than that of a carrot, and it contains high levels of amino acids. 7, 8 According to many studies, aglycone in burdock is an active ingredient that inhibits urinary protein excretion, and can improve serum biochemical indicators. 9, 10 It also demonstrates antinephritic activity, and can be used to treat acute nephritis, nephrotic syndrome, and prevents senile dementia. 11, 12 The burdock plant contains antibacterial ingredients, which have shown the ability to inhibit Staphylococcus species and show different degrees of inhibitory action against a variety of pathogenic fungi. 13−15 Moreover, the ingredients of burdock have been demonstrated to reduce acid-induced chronic gastric ulcers by 52%, reduce oxidative stress and cell injury in liver cells, 9, 10 and show antitumor activity. 16 To verify the efficacy of burdock-processed foods as supplements for medication, this study assessed whether burdock essence is able to promote gastrointestinal repair in peptic ulcer patients.
Materials and Methods

Testing burdock
In this study, we tested burdock essence in tablets at concentration of 500 mg/tablet. The Dong Yuan Biotech Pharmaceutical Co., Ltd. commissioned the Ko Da Pharmaceutical Co., Ltd. to manufacture processed food from burdock (the sample). The sample underwent a quality assurance test conducted by Tajen University and then passed the commissioned safety assessment test conducted by Taipei Medical University. The sample was consistent with the norms stipulated by the Health Food Management Law and the request for certification of burdock as a health food was accepted (No. A00139, letter of the Department of Health, Executive Yuan).
Patient selection and specimen collection
The clinical trials in this study included patients in the Division of Gastroenterology, Pingtung Christian Hospital. A total of 30 case studies were included in the study. Patients had to be aged 20−80 years with endoscopic confirmation of gastric or duodenal ulcers, and a lesion size ranging from 0.5−2.0 cm. Those patients undergoing treatment or suffering from severe systematic diseases, including chronic obstructive pulmonary disease, congestive heart failure and malignant tumors, were excluded. Those who were accepted after receiving a detailed explanation were asked to sign a consent form. A doubleblind experiment was then carried out for all patients who continued in an original treatment approach. Two tablets of burdock essence (500 mg/tablet) were orally administered in the experimental group three times a day after meals, while the control group was given a placebo. During the experimental period, the subjects were required to take medication for 4 weeks and undergo various tests (described below) before and after drug administration to assess the efficacy of burdock essence.
Gastric mucosal damage index analysis
Gastric mucosal lesions of peptic ulcer patients were examined by electronic endoscopy (GIF-Q260; Olympus Corp; Tokyo, Japan). The gastric mucosal lesions were then photographed using an electronic endoscope to compare the gastric mucosa damage ulcer index with the naked eye.
Identification of H. Pylori infection
A rapid urease test was conducted on all tissue samples removed from the peptic ulcer patients through electronic endoscopy at the time of the examination. Test results of "pink" and "yellow" signified positive and negative H. pylori infection, respectively. 
Results
Endoscopy confirmed that the 30 patients enrolled in the study had gastric or duodenal ulcers, and the experiment begun after patient consent. Among the 30 patients, three could not undergo follow-up examinations. Of the three patients, one failed to make the subsequent scheduled visit (experimental group), the family of the second patient did not approve of the experiment (experimental group), and the third patient withdrew owing to lower extremity edema (placebo group). At the conclusion of the burdock essence clinical trials, the remaining 27 patients were included in the statistical analysis. The clinical trial included 27 patients with an age range of 35−77 years and an average age of 57. Eighteen patients were male and nine were female (Table 1) .
With regard to the gastric mucosal damage index, of the 20 patients who had taken burdock essence, 17 (85%) healed completely and three (15%) did not (Table 2 and Figure 1) . Moreover, among the seven patients who had taken placebos, five (71%) were not completely healed and two (29%) were completely healed. Three patients in the burdock essence experimental group had ulcer wounds that did not heal completely; however, their ulcer damage was reduced by 30%, 75%, and 33% (Table 2 and Figure 2 ). Urease test results showed that the patients designated 1 through 8 in the burdock essence experimental group tested negative for H. pylori infection either before or after the trial. Patients designated as numbers 9 and 19 tested positive for H. pylori infection, but their gastric ulcer repair showed improvement in scab formation. Patients 10 through 18, and patient 20 were positive for H. pylori infection before the trial, while urease tests for H. pylori infection had a negative result after the trial (Tables 2 and 3 ). The gastric mucosal damage index results and the H. pylori test suggested that burdock essence promoted gastrointestinal mucosal healing in patients with gastric or duodenal ulcers, and improved the effect of medication on the suppression of H. pylori infection.
Discussion
Our findings suggest that the scope of applications for the use of burdock essence should include healthy individuals and patients experiencing gastrointestinal discomfort. Because of modern-day eating habits, which include processed, low-fiber and fast food, people face the considerable threat of suffering from gastrointestinal diseases. Intake of burdock essence 
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products daily in suitable quantities may benefit healthy individuals by protecting their gastrointestinal tract from damage by oily foods, life stresses, and even H. pylori, consequently reducing the risk of gastrointestinal diseases (i.e. disease prevention). According to several medical reports, 18−20 most gastric ulcer patients are infected with H. pylori, and after eliminating this infection, reoccurrence of gastric ulcers is rare. Burdock essence has been shown to induce H. pylori antibodies in the blood serum and inhibit H. pylori in in vitro tests.
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The results of the present study indicate the efficacy of burdock essence in peptic ulcer disease. Our data showed that in most patients who were given burdock essence, 85% were completely healed. On the other hand, we also found that most of the patients who took placebos were not completely healed. Several of the patients in the burdock essence group also had a reduction in size of their wounds. In addition, in the burdock essence group, almost all of the patients who were positive for H. pylori (91%) were negative for H. pylori after the trial, indicating that burdock essence aids in the inhibition of H. pylori. In summary, taking two tablets (500 mg/tablet) of burdock essence three times a day after meals promotes gastric mucosal repair in gastrointestinal ulcer patients, and augments the inhibitory effect of the original medication on H. pylori. Therefore, this processed food of botanical origin may be beneficial for use as a supplement in treating patients with gastrointestinal discomfort. Moreover, burdock essence may potentially become a health food supplement used to prevent the recurrence of peptic ulcer disease. 
